Price of new Hep C drugs ‘unsustainably high’

Manufacturers charging HSE between €45,000 and €80,000 for 12-week courses

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
13th March, 2016

The Irish Haemophilia Society has urged the HSE to initiate a public tender to source new medicines to cure Hepatitis C.

The organisation’s chief executive Brian O’Mahony said the price being charged by manufacturers in Ireland for the newest HepC medicines was “unsustainably high.”

Manufacturers are charging the HSE between €45,000 and €80,000 for a 12-week course of the new medicines in various combinations, with a cure rate of...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Updated costs on new children’s hospital cannot be released, says Watt

Children from poorer families at a disadvantage in education and health, research shows

Tony O’Brien: Draft contract adds to bad blood between Department of Health and consultants

Health Tony O'Brien 6 days ago

Multi-annual health budget mooted to tackle waiting lists

Health Daniel Murray 1 week ago